Canonical: https://ownershiptrace.com/13f/companies/1401

# Who owns UNITED THERAPEUTICS Corp (UTHR)? Elite investor 13F holders

5 tracked elite investors reported holding UNITED THERAPEUTICS Corp as of 2026-06-30, including Renaissance Technologies LLC, Bridgewater Associates, Gotham Asset Management, GMO, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil)…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 925846052.00 USD | 1708739.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 60319767.00 USD | 111326.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 42871215.00 USD | 79123.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [GMO](https://ownershiptrace.com/13f/investors/94674) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1775577.00 USD | 3277.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1352662/0001072613-26-000636-index.html) |
| [Mairs & Power Funds](https://ownershiptrace.com/13f/investors/54) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1070134/0001172661-26-003496-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5418.00 USD | 10.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)